Stable preparations of anti-CTLA4 antibodies alone and in combination with programmed kill receptor 1 (PD-1) antibodies and methods of use thereof

摘要

The present invention includes an antibody or antigen binding fragment thereof that binds to cytotoxic T lymphocyte associated antigen 4 (CTLA4) and optionally comprises an anti-human programmed death receptor 1 (PD-1) antibody or antigen binding fragment thereof. It further relates to a stable formulation containing. Also provided are methods of treating various cancers and chronic infections using the formulations of the present invention.